Elsevier

Life Sciences

Volume 67, Issue 13, 18 August 2000, Pages 1653-1658
Life Sciences

Pharmacology letters
The effects of A-ring and D-ring metabolites of estradiol on the proliferation of vascular endothelial cells

https://doi.org/10.1016/S0024-3205(00)00747-5Get rights and content

Abstract

The effects of 14 estradiol metabolites on the proliferation of cultured endothelial cells of human umbilical cord veins were examined and compared with that of their parent substance estradiol. The relationship between dosage and effect was tested over the pharmacological concentration range of 10−8 to 10−5 M. Estradiol showed a biphasic behaviour, in the form of stimulation at low concentrations and inhibition at the highest concentration. All 10 A-ring metabolites tested stimulated the growth of the endothelial cells at the lower concentrations. At the highest concentration, the 5 A-ring metabolites: 2-hydroxyestrone, 2-hydroxyestradiol, 2-hydroxyestriol, 4-hydroxyestrone and 4-hydroxyestradiol caused significant inhibitions. Except for the 2-hydroxyestradiol, methylation of these metabolites resulted in the loss of the proliferation inhibiting effect. The D-ring metabolites showed no marked effects compared to the A-ring metabolites except for 16α-hydroxyestrone which had an inhibiting effect from 10−7 to 10−5 M. Our results show that estradiol metabolites can influence the growth of vascular endothelial cells in the concentration range tested. While the antiproliferative action of 2-methoxyestradiol has been known for some time this study is the first to show the potential capacity of non-methylated metabolites of the A-ring metabolism in inhibiting endothelial proliferation. This may open up new clinical pharmacological aspects in the anti-angiogenetic treatment of tumors.

References (0)

Cited by (49)

  • Sensitivity of the LuminoTox tool to monitor contaminants of emerging concern in municipal secondary wastewater effluent

    2017, Science of the Total Environment
    Citation Excerpt :

    In some cases, samples that elicited an inhibition statistically equivalent to their blank, had one or more replicate exhibiting a stimulation (negative inhibition), which is a hormetic effect that was also observed in other LuminoTox studies (Gesuale et al., 2010; Mamindy-Pajany et al., 2011). Hormetic effects have also been reported for other assays and are known to be independent of species, mode of action and toxicant (Calabrese & Baldwin, 2002; De Nicola et al., 2007; Lippert et al., 2000; Mamindy-Pajany et al., 2011). In only 3 of high-range conditions tested resulted in significantly higher inhibitions compared to their blanks, while the remainder were statistically equivalent as confirmed by Paired t-tests.

  • Raloxifene<sup>*</sup>*Lilly Research Laboratories, Indianapolis, Indiana. increases proliferation of human endothelial cells in association with increased gene expression of cyclins A and B1

    2007, Fertility and Sterility
    Citation Excerpt :

    This point is of interest because, as suggested for Es (4), raloxifene might have a protective effect against cardiovascular disease when administered to women during the early postmenopausal period. It is important to stress that the magnitude of the proliferative effect was similar to that induced by E2 (24,25). Moreover, this effect was observed at a similar concentration range of 1 nM–10 nM.

View all citing articles on Scopus
View full text